Keywords: biomarin, partner, submits, naglazyme, bla, japan, california

BioMarin partner submits Naglazyme BLA in Japan

Article | 20 August 2007

California, USA-based BioMarin Pharmaceutical says that AnGes MG, its marketing and distribution partner in Japan, has submitted a Biologics License ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Galsulfase

Naglazyme

Go to drug listing